+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 153 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 6052219
Description Jump to:
The global sepsis therapeutics market size is anticipated to reach USD 5.64 billion by 2030, growing at a CAGR of 6.18% from 2025 to 2030. The sepsis therapeutics industry is experiencing significant growth due to the increasing prevalence of sepsis and the rising demand for effective treatment options. Sepsis, a life-threatening condition triggered by an infection, is a leading cause of mortality globally, particularly among vulnerable populations such as the elderly and those with compromised immune systems. The growing awareness about sepsis, alongside advancements in healthcare infrastructure, is driving the demand for novel and effective therapies, propelling market growth.

A key factor contributing to the expansion of the market is the wide range of antibiotics used in the treatment. Aminoglycosides, such as gentamicin, continue to be a mainstay in sepsis management due to their broad-spectrum activity against Gram-negative bacteria. Additionally, cephalosporins are widely prescribed because of their effectiveness in treating various infections, especially those caused by Gram-positive bacteria. Glycopeptides, such as vancomycin, are also critical in sepsis therapy, particularly for resistant infections. The presence of other drug classes like carbapenems and beta-lactams further enhances the treatment landscape.

The availability of sepsis therapeutics in various forms, including oral, parenteral (injectable), and other formulations, ensures better accessibility and versatility for patients across different healthcare settings. Oral medications are convenient for outpatient treatment, while parenteral formulations are vital for severe cases requiring immediate intervention. The growing availability of other drug forms also supports personalized care.

In terms of distribution channels, hospital pharmacies continue to be the primary source of sepsis therapeutics, ensuring that critical care units are stocked with necessary treatments. Retail pharmacies are expanding their role in providing accessible medications, while online pharmacies are gaining traction by offering easy access to sepsis drugs, further boosting market growth. As healthcare access and treatment awareness increase globally, the sepsis therapeutics industry is poised for continued expansion in the coming years.

Sepsis Therapeutics Market Report Highlights

  • The drug class segment of cephalosporins held the largest market share in 2024. This dominance can be attributed to the broad-spectrum efficacy of cephalosporins against a wide range of bacterial infections, including both Gram-positive and Gram-negative pathogens.
  • In the route of administration segment, parenteral formulations dominated the market in 2024. Parenteral drugs, including intravenous and intramuscular injections, offer rapid delivery and higher bioavailability, making them essential for the immediate treatment of sepsis, especially in critical care settings.
  • Based on distribution channel, hospital pharmacies remained the dominant segment in 2024. Hospital pharmacies are critical in ensuring timely and adequate provision of sepsis therapeutics, particularly in intensive care units (ICUs) and emergency departments where quick access to lifesaving treatments is essential.
  • North America dominated the market for sepsis therapeutics in 2024, owing to factors such as advanced healthcare infrastructure, rising disease prevalence, and favorable regulatory environment.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Sepsis Therapeutics Market Variables, Trends, & Scope
3.1. Parent Market Outlook
3.2. Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Increasing prevalence of sepsis cases
3.3.1.2. Advancements in modern therapeutics
3.3.1.3. Rising investment in sepsis research and drug development
3.3.2. Market Restraints Analysis
3.3.2.1. High cost of advanced therapies
3.3.2.2. Lack of awareness and early diagnosis in some regions
3.4. Sepsis Therapeutics Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Sepsis Therapeutics Market: Type Estimates & Trend Analysis
4.1. Sepsis Therapeutics Market: Type Segment Dashboard
4.2. Sepsis Therapeutics Market: By Type Movement Analysis, 2024 & 2030 (USD Million)
4.3. Cephalosporin
4.3.1. Cephalosporin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Aminoglycosides
4.4.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Glycopeptide
4.5.1. Glycopeptide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Other Drug Class
4.6.1. Other Drug Class Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Sepsis Therapeutics Market: Route of Administration Estimates & Trend Analysis
5.1. Sepsis Therapeutics Market: Route of Administration Segment Dashboard
5.2. Sepsis Therapeutics Market: By Route of Administration Movement Analysis, 2024 & 2030 (USD Million)
5.3. Parenteral
5.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Oral
5.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Sepsis Therapeutics Market: Distribution Channel Estimates & Trend Analysis
6.1. Sepsis Therapeutics Market: Distribution Channel Segment Dashboard
6.2. Sepsis Therapeutics Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospital Pharmacies
6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Online Pharmacies
6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Sepsis Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Sepsis Therapeutics Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
7.2.1. North America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Sepsis Therapeutics Market Estimates and Forecasts, 2018- 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Sweden Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Sepsis Therapeutics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Kuwait
7.6.4.1. Kuwait Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. South Africa Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Pfizer, Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. GSK plc.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. AstraZeneca
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Eli Lilly and Company
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Astellas Pharma Inc.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Asahi Kasei Corporation
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. InflaRx GmbH
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. La Jolla Pharmaceutical Co.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. T2 Biosystems Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Aridis Pharmaceuticals Inc.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 4 Global Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 5 Global Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 6 North America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 8 North America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 9 North America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S. Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 11 U.S. Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 12 U.S. Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Canada Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 14 Canada Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 15 Canada Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Mexico Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 17 Mexico Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 18 Mexico Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Europe Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 21 Europe Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 22 Europe Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Germany Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 24 Germany Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 25 Germany Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 26 UK Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 27 UK Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 28 UK Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 France Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 30 France Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 31 France Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Italy Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 33 Italy Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 34 Italy Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Spain Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 36 Spain Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 37 Spain Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Denmark Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 39 Denmark Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 40 Denmark Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Sweden Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 42 Sweden Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 43 Sweden Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Norway Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 45 Norway Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 46 Norway Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 China Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 52 China Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 53 China Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 54 Japan Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 55 Japan Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 56 Japan Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 57 India Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 58 India Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 59 India Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 61 South Korea Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 62 South Korea Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Australia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 64 Australia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 65 Australia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Thailand Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 67 Thailand Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 68 Thailand Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Latin America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 71 Latin America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 72 Latin America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Brazil Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 74 Brazil Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 75 Brazil Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Argentina Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 77 Argentina Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 78 Argentina Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 83 South Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 84 South Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 85 South Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 89 UAE Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 90 UAE Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 91 UAE Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Kuwait Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
Table 93 Kuwait Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 94 Kuwait Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Sepsis therapeutics market Segmentation
Fig. 8 Market Snapshot, 2024
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Market challenge relevance analysis (current & future impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Sepsis therapeutics market: Drug class movement analysis
Fig. 16 Sepsis therapeutics market: Drug class Outlook and key takeaways
Fig. 17 Cephalosporin sepsis therapeutics market estimates and forecasts, 2018 - 2030
Fig. 18 Aminoglycosides sepsis therapeutics market estimates and forecasts, 2018 - 2030
Fig. 19 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
Fig. 20 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
Fig. 21 Sepsis therapeutics market: Treatment movement analysis
Fig. 22 Sepsis therapeutics market: Treatment outlook and key takeaways
Fig. 23 Parenteral market estimates and forecasts, 2018 - 2030
Fig. 24 Oral market estimates and forecasts, 2018 - 2030
Fig. 25 Others market estimates and forecasts, 2018 - 2030
Fig. 26 Sepsis therapeutics market: Distribution channel movement analysis
Fig. 27 Sepsis therapeutics market: Distribution channel outlook and key takeaways
Fig. 28 Hospital pharmacies market estimates and forecasts, 2018 - 2030
Fig. 29 Retail pharmacies market estimates and forecasts, 2018 - 2030
Fig. 30 Online pharmacies market estimates and forecasts, 2018 - 2030
Fig. 31 Regional Marketplace: Key Takeaways
Fig. 32 Regional Outlook, 2024 & 2030
Fig. 33 Global sepsis therapeutics market, Region Movement Analysis
Fig. 34 North America sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 35 U.S. sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 36 Canada sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 37 Mexico sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 38 Europe sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 39 Germany sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 40 UK sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 41 France sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 42 Italy sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 43 Spain sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 44 Denmark sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 45 Sweden sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 46 Norway sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 48 Japan sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 49 China sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 50 India sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 51 Australia sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 52 South Korea sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 53 Thailand sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 54 Latin America sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 55 Brazil sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 56 Argentina sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 58 South Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 60 UAE sepsis therapeutics market, 2018 - 2030 (USD Million)
Fig. 61 Kuwait sepsis therapeutics market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Pfizer, Inc.
  • GSK plc.
  • AstraZeneca plc
  • Eli Lilly and Company
  • Astellas Pharma Inc.
  • Astellas Pharma Inc.
  • InflaRx GmbH
  • La Jolla Pharmaceutical Co.
  • T2 Biosystems Inc.
  • Aridis Pharmaceuticals Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages153
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.64 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Sepsis Therapeutics - Global Strategic Business Report - Product Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • 291 Pages
  • Global
From
Sepsis- Pipeline Insight, 2024 - Product Image

Sepsis- Pipeline Insight, 2024

  • Clinical Trials
  • 80 Pages
  • Global
From
Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 131 Pages
  • Global
From
Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 133 Pages
  • Global
From
Vancomycin - Global Strategic Business Report - Product Image

Vancomycin - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From

About the Market

The Sepsis Drug market is a subset of the larger Infectious Diseases Drugs market. Sepsis is a life-threatening condition caused by the body's response to an infection. It is a major cause of death worldwide, and the drugs used to treat it are an important part of the Infectious Diseases Drugs market. Sepsis drugs are typically antibiotics, antifungals, antivirals, and other immunomodulators. These drugs are used to reduce the severity of the infection and to prevent further complications. The Sepsis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Other companies such as Novartis, Bristol-Myers Squibb, and Eli Lilly also have a presence in the market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.